Cargando…
CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation
Atherosclerosis is an arterial inflammatory disease. The circulating level of the C-C chemokine ligand (CCL4) is increased in atherosclerotic patients. This study aimed to investigate whether CCL4 inhibition could retard the progression of atherosclerosis. In ApoE knockout mice, CCL4 antibody treatm...
Autores principales: | Chang, Ting-Ting, Yang, Hsin-Ying, Chen, Ching, Chen, Jaw-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555143/ https://www.ncbi.nlm.nih.gov/pubmed/32911750 http://dx.doi.org/10.3390/ijms21186567 |
Ejemplares similares
-
CCL4 Deletion Accelerates Wound Healing by Improving Endothelial Cell Functions in Diabetes Mellitus
por: Chang, Ting-Ting, et al.
Publicado: (2022) -
CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease
por: Chang, Ting-Ting, et al.
Publicado: (2022) -
Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis
por: Wu, Yen-Wen, et al.
Publicado: (2020) -
Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus
por: Chang, Ting-Ting, et al.
Publicado: (2021) -
Hyaluronan
Nanoparticles Selectively Target Plaque-Associated Macrophages and
Improve Plaque Stability in Atherosclerosis
por: Beldman, Thijs J., et al.
Publicado: (2017)